6:11 PM
 | 
Nov 17, 2009
 |  BC Extra  |  Company News

FDA to discuss REMS for opioid drugs

FDA will hold a meeting on Dec. 4 to discuss risk evaluation and mitigation strategies (REMS) for...

Read the full 65 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >